Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
RESEARCH TOOLSreports
Holding IOVA?
Track your performance easily
Iovance Biotherapeutics (IOVA) Ownership Overview
9.58% Insiders
14.94% Mutual Funds
36.49% Other Institutional Investors
16.95% ETFs
22.04% Public Companies and Individual Investors
The ownership structure of Iovance Biotherapeutics (IOVA) stock is a mix of institutional, retail, and individual investors. Approximately 68.38% of the company’s stock is owned by Institutional Investors, 9.58% is owned by Insiders, and 22.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 14, 2024 | Ryan Maynard Director | xxxxxxxxxxxxx | $503000 |
| Feb 20, 2024 | Iain D. Dukes Director | xxxxxxxxxxxxx | $292800 |
| Feb 20, 2024 | Wayne P. Rothbaum Director | xxxxxxxxxxxxx | $45750000 |
| Feb 20, 2024 | Merrill A Mcpeak Director | xxxxxxxxxxxxx | $2287500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $1380330 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,067,333 | Insider | 9.21% | 229,871,457 | |
| 26,617,709 | Institution | 8.73% | 217,999,037 | |
| 25,838,265 | Institution | 8.48% | 211,615,390 | |
| 22,239,865 | Institution | 7.30% | 182,144,494 | |
| 12,579,661 | Institution | 4.13% | 103,027,424 | |
| 8,021,610 | Institution | 2.63% | 65,696,986 | |
| 2,920,334 | Institution | 0.96% | 23,917,535 | |
| 2,563,567 | Institution | 0.84% | 20,995,614 | |
| 2,423,725 | Institution | 0.80% | 19,850,308 | |
| 1,595,062 | Institution | 0.52% | 13,063,558 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 22,239,865 | Institution | 7.30% | 182,144,494 | |
| 2,920,334 | Institution | 0.96% | 23,917,535 | |
| 2,563,567 | Institution | 0.84% | 20,995,614 | |
| 2,423,725 | Institution | 0.80% | 19,850,308 | |
| 1,595,062 | Institution | 0.52% | 13,063,558 | |
| 1,408,584 | Institution | 0.46% | 11,536,303 | |
| 1,285,209 | Institution | 0.42% | 10,525,862 | |
| 1,279,288 | Institution | 0.42% | 10,477,369 | |
| 1,107,215 | Institution | 0.36% | 9,068,091 | |
| 993,377 | Institution | 0.33% | 8,135,758 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,712,543 | Institution | 2.86% | 81,810,779 | |
| 6,831,449 | Institution | 2.24% | 64,147,306 | |
| 6,901,943 | Institution | 2.26% | 58,183,379 | |
| 6,955,979 | Institution | 2.28% | 56,969,468 | |
| 4,630,333 | Institution | 1.52% | 43,478,827 | |
| 3,382,666 | Institution | 1.11% | 31,763,234 | |
| 2,279,564 | Institution | 0.75% | 18,669,629 | |
| 1,705,002 | Institution | 0.56% | 13,963,966 | |
| 1,161,172 | Institution | 0.38% | 10,903,405 | |
| 1,088,864 | Institution | 0.36% | 9,179,124 |
FAQ
Who Owns Iovance Biotherapeutics Inc (IOVA)?
According to the latest TipRanks data, approximately 36.49% of the company's stock is held by institutional investors, 9.58% is held by insiders, and 22.04% is held by retail investors.
What percentage of Iovance Biotherapeutics Inc (IOVA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.49% of Iovance Biotherapeutics Inc (IOVA) stock is held by institutional investors.
What percentage of Iovance Biotherapeutics Inc (IOVA) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.04% of Iovance Biotherapeutics Inc (IOVA) stock is held by retail investors.
Who owns the most shares of Iovance Biotherapeutics Inc (IOVA)?
Wayne P. Rothbaum owns the most shares of Iovance Biotherapeutics Inc (IOVA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.